197 related articles for article (PubMed ID: 21387308)
1. The burden of cervical cancer in China: synthesis of the evidence.
Shi JF; Canfell K; Lew JB; Qiao YL
Int J Cancer; 2012 Feb; 130(3):641-52. PubMed ID: 21387308
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study.
Dai M; Bao YP; Li N; Clifford GM; Vaccarella S; Snijders PJ; Huang RD; Sun LX; Meijer CJ; Qiao YL; Franceschi S
Br J Cancer; 2006 Jul; 95(1):96-101. PubMed ID: 16773069
[TBL] [Abstract][Full Text] [Related]
3. The burden of cervical cancer in Vietnam: Synthesis of the evidence.
Thi Nguyen DN; Simms K; Vu Nguyen HQ; Van Tran T; Nguyen NH; LaMontagne DS; Castle P; Canfell K
Cancer Epidemiol; 2019 Apr; 59():83-103. PubMed ID: 30710841
[TBL] [Abstract][Full Text] [Related]
4. Effects of exposure to polycyclic aromatic hydrocarbons combined with high-risk human papillomavirus infection on cervical intraepithelial neoplasia: A population study in Shanxi Province, China.
Li X; Ding L; Song L; Gao W; Wang L; Wang J
Int J Cancer; 2020 May; 146(9):2406-2412. PubMed ID: 31290154
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study.
Shi JF; Canfell K; Lew JB; Zhao FH; Legood R; Ning Y; Simonella L; Ma L; Kang YJ; Zhang YZ; Smith MA; Chen JF; Feng XX; Qiao YL
BMC Cancer; 2011 Jun; 11():239. PubMed ID: 21668946
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and carcinogenic risk of high-risk human papillomavirus subtypes in different cervical cytology: a study of 124,251 cases from the largest academic center in China.
Tao X; Zhang H; Wang S; Chen T; Cong Q; Wang L; Zhou X; Zhao C
J Am Soc Cytopathol; 2021; 10(4):391-398. PubMed ID: 33906830
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence of human papillomavirus infection and risk of cervical cancer or precancerous lesions in 15 years follow up: a prospective cohort study].
Zhang Q; Hu SY; Feng RM; Dong L; Chen F; Zhang X; Pan QJ; Ma JF; Shi SD; Zhao FH; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):792-797. PubMed ID: 27784468
[No Abstract] [Full Text] [Related]
9. [Study of the association between human papillomavirus infection and cervical cancer in Xianguan county, Shanxi province].
Zhao F; Li N; Ma J
Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Oct; 22(5):375-8. PubMed ID: 11769697
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of cervical human papillomavirus (HPV) infection in Vanuatu.
Aruhuri B; Tarivonda L; Tenet V; Sinha R; Snijders PJ; Clifford G; Pang J; McAdam M; Meijer CJ; Frazer IH; Franceschi S
Cancer Prev Res (Phila); 2012 May; 5(5):746-53. PubMed ID: 22427345
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of human papillomavirus infection among women with and without normal cervical histology in Shandong Province, China.
Yuan X; Yang Y; Gu D; Liu H; Yang H; Wang M
Arch Gynecol Obstet; 2011 Jun; 283(6):1385-9. PubMed ID: 20628750
[TBL] [Abstract][Full Text] [Related]
12. Prevalence characteristics of single and multiple HPV infections in women with cervical cancer and precancerous lesions in Beijing, China.
Li M; Du X; Lu M; Zhang W; Sun Z; Li L; Ye M; Fan W; Jiang S; Liu A; Wang M; Meng Y; Li Y
J Med Virol; 2019 Mar; 91(3):473-481. PubMed ID: 30281807
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study.
Wu EQ; Liu B; Cui JF; Chen W; Wang JB; Lu L; Niyazi M; Zhao C; Ren SD; Li CQ; Gong XZ; Smith JS; Belinson JL; Liaw KL; Velicer C; Qiao YL
Cancer Causes Control; 2013 Apr; 24(4):795-803. PubMed ID: 23397310
[TBL] [Abstract][Full Text] [Related]
14. Risks for cervical abnormalities in women with non-16/18 high-risk human papillomavirus infections in south Shanghai, China.
Wang X; Wu S; Li Y
J Med Virol; 2021 Nov; 93(11):6355-6361. PubMed ID: 34232523
[TBL] [Abstract][Full Text] [Related]
15. The distribution and prevalence of human papillomavirus in women in mainland China.
Li K; Li Q; Song L; Wang D; Yin R
Cancer; 2019 Apr; 125(7):1030-1037. PubMed ID: 30748006
[TBL] [Abstract][Full Text] [Related]
16. Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.
Zhao FH; Zhu FC; Chen W; Li J; Hu YM; Hong Y; Zhang YJ; Pan QJ; Zhu JH; Zhang X; Chen Y; Tang H; Zhang H; Durand C; Datta SK; Struyf F; Bi D;
Int J Cancer; 2014 Dec; 135(11):2604-11. PubMed ID: 24740547
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between multiple infection of human papillomavirus and cervical neoplasia among Chinese women in urban areas].
Li N; Dai M
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 May; 44(5):423-6. PubMed ID: 20654232
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of high-risk human papillomavirus and incidence of cervical intraepithelial neoplasia in female populations in Shenzhen, Guangdong Province].
Wu RF; Liu ZH; Zhou QZ; Wulan N; Wang Q; Li Q; Li N; Liu ZH; Shi JF; Li RZ; Zhang CH; Zhou YQ; Liu B; Weng LM; Qiao YL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Feb; 32(1):90-5. PubMed ID: 20236596
[TBL] [Abstract][Full Text] [Related]
19. Prevalence characteristics of cervical human papillomavirus (HPV) infection in the Zhoupu District, Shanghai City, China.
Li H; Li P; Huang L; Sun L; Ren H; Li P
Virol J; 2020 Jun; 17(1):84. PubMed ID: 32586352
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus (HPV) type distribution in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesions in Venezuelan women.
Correnti M; Medina F; Cavazza ME; Rennola A; Avila M; Fernándes A
Gynecol Oncol; 2011 Jun; 121(3):527-31. PubMed ID: 21421263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
